GE HealthCare Technologies (GEHC) Common Equity (2022 - 2026)

GE HealthCare Technologies has reported Common Equity for 5 years, with the latest figure at $10.7 billion in Q1 2026.

• For the quarter ending Q1 2026, Common Equity rose 16.0% year-over-year to $10.7 billion; the trailing twelve-month figure through Mar 2026 stood at $10.7 billion (up 16.0% YoY), and the FY2025 full-year result was $10.4 billion, up 22.76% from the prior year.
• Common Equity for Q1 2026 stood at $10.7 billion, up from $10.4 billion in the prior quarter.
• The five-year high for Common Equity was $17.1 billion in Q2 2022, with the low at $6.7 billion in Q1 2023.
• Historically, Common Equity has averaged $10.0 billion across 5 years, with a median of $9.2 billion in 2025.
• Annual changes were most pronounced in 2023 — Common Equity tumbled 59.61% — and 2025, when it rose 24.51%.
• GE HealthCare Technologies' Common Equity stood at $9.4 billion in 2022, then slipped by 23.68% to $7.1 billion in 2023, then increased by 18.46% to $8.5 billion in 2024, then climbed by 22.76% to $10.4 billion in 2025, then climbed by 2.79% to $10.7 billion in 2026.
• The last three Common Equity figures came in at $10.7 billion (Q1 2026), $10.4 billion (Q4 2025), and $10.0 billion (Q3 2025), per Business Quant data.